Pfizer targets GLP-1 leadership despite 2028 launch
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
Pfizer says it can become a dominant player in the GLP-1 market, projected to reach Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context